TL
HALO icon

Tirschwell & Loewy’s Halozyme HALO Stock Holding History

Tirschwell & Loewy’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-195,367
Closed -$2.16M – 85
2013
Q3 		$2.16M Sell
195,367
-378,016
-66% -$3.15M 0.42% 49
2013
Q2 		$4.56M Buy
+573,383
New +$3.65M 0.97% 33

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tirschwell & Loewy's HALO Position: Q4 2013 in Review

Tirschwell & Loewy sold out of Halozyme (HALO) in Q4 2013, closing a stake of 195,367 shares — an estimated $2.16M sold.

Tirschwell & Loewy first reported a position in HALO in Q2 2013 and held it in 2 quarters. The position peaked at $4.56M in Q2 2013. 119 funds tracked by Wall St. Rank hold HALO as of Q4 2013.

  • Tirschwell & Loewy reported no remaining Halozyme position as of Q4 2013 after selling out during the quarter.
  • Tirschwell & Loewy sold 195,367 Halozyme shares in Q4 2013, an estimated $2.16M.
  • Tirschwell & Loewy first reported a position in Halozyme in Q2 2013 and held it in 2 quarters.
  • Tirschwell & Loewy's Halozyme position peaked at $4.56M in Q2 2013.
  • 119 funds tracked by Wall St. Rank held Halozyme as of Q4 2013.

Based on Tirschwell & Loewy's 13F filing for Q4 2013, filed 10 Jan 2014.